News Releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 23, 2019Top-line Data Expected in the Fourth Quarter of 2019
-
Apr 11, 2019Financing to fund pre-launch commercialization activities of Amphora® (L-lactic acid, citric acid, and potassium bitartrate), a novel, investigational non-hormonal, on-demand, female contraceptive
-
Mar 1, 2019Positive Phase 3 Amphora Results Enabling NDA Submission
-
Feb 19, 2019-- Conference Call Scheduled for 11:00 a.m. EST --
-
Jan 3, 2019- Company to Resubmit New Drug Application (NDA) for Amphora as Hormone-free Birth Control in Q2 2019 Based on Positive Top-line Phase 3 Study Results -
-
Nov 8, 2018-- Company Remains on Track for AMPOWER Top-line Results in Late 2018 --